Soul singer Charles Bradley has died from stomach cancer at the age of 68.
The former James Brown impersonator, nicknamed “the screaming eagle of soul” found fame in his later years. He released his first album No Time For Dreaming in 2011, aged 62.
Charles Bradley had recently returned to live performance after receiving treatment for stomach cancer late last year.
The singer’s death comes just two weeks after the remainder of his 2017 tour dates were canceled due to illness.
Charles Bradley spent much of his life working odd jobs as a handyman – and some of it living on the streets, sleeping in subway cars in New York City.
However, he continued to pursue music, having been inspired by James Brown during a performance he saw as a teenager.
Image source Wikimedia
Charles Bradley was eventually signed to a New York label in the early 2000s, securing a spot as the opening act on tour for soul revival singer Sharon Jones – who died last year aged 60.
He recorded a string of singles before the release of No Time for Dreaming a decade later. It was named one of Rolling Stone magazine’s best albums of the year.
Charles Bradley’s critical success led to live performances at some of the world’s top music festivals, including Glastonbury, Coachella, and Primavera Sound.
His rags-to-riches story was the subject of the documentary Charles Bradley: Soul of America. It followed Charles Bradley from his initial signing to the record label, living in crippling debt, to his sold-out album release show.
Earlier in September, when announcing the tour’s cancelation, a message attributed to Charles Bradley on his social media accounts said: “I love all of you out there that made my dreams come true.
“When I come back, I’ll come back strong, with God’s love. With God’s will, I’ll be back soon.”
Confirming news of Charles Bradley’s death, his publicist said: “Mr. Bradley was truly grateful for all the love he’s received from his fans and we hope his message of love is remembered and carried on.”
9/11 survivor Marcy Borders, who is known as “Dust Lady” after being photographed covered in dust while fleeing the World Trade Center, has died of stomach cancer at the age of 42.
Marcy Borders’ death was announced by her family on Facebook.
The woman was diagnosed with stomach cancer in 2014 at the age of 41.
The iconic 9/11 photo of Marcy Borders was taken by AFP photographer Stan Honda as the attacks on the Twin Towers unfolded.
Marcy Borders, who was 28 at the time of the attacks, was working on the 81st floor of the World Trade Center’s North Tower when the first plane hit. She fled down the stairwell and emerged from the building as the South Tower fell, covering her in dust and debris.
Photo Jersey Journal
She said a stranger pulled her to safety in a nearby building, where Stan Honda took the now-famous photo.
Marcy Borders kept the clothes she was wearing – still covered in ash – in a plastic bag in her wardrobe, but as of 2011 had never looked at them, the Telegraph reported.
In the next 10 years following 9/11 attacks, Marcy Borders grappled with depression and substance abuse. She checked into a rehab center in 2011.
In an interview with the Jersey Journal in 2014, Marcy Borders speculated that her cancer was related to the attacks.
The number of cancer cases linked to 9/11 attacks has grown in recent years.
As of May 2015, the Centers for Disease Control and Prevention (CDC) reported more than 4,000 first responders, rescue workers and survivors who have been diagnosed with cancer linked to the attacks.
The CDC said skin cancer, prostate cancer and non-Hodgkin’s lymphoma are among the most common illnesses among those individuals.
Animal tests suggested that Botox injections may help fight cancer.
The new study, published in Science Translational Medicine, showed nerves help stomach cancers grow.
Research on mice found that using the toxin beloved by those seeking a wrinkle-free face to kill nerves could halt the growth of stomach tumors and make them more vulnerable to chemotherapy.
Botox is usually used in the fight against the signs of ageing, not cancer.
The toxin disrupts nerve function to relax muscles and even out wrinkles, but a growing body of work suggests nerves can also help fuel cancer growth.
Scientists Columbia University Medical Centre, in New York, and the Norwegian University of Science and Technology in Trondheim investigated the role of the vagus nerve – which runs from the brain to the digestive system – in stomach cancer.
Research on mice found that using Botox to kill nerves could halt the growth of stomach tumors and make them more vulnerable to chemotherapy
Either cutting the nerve or using the toxin Botox slowed the growth of tumors or made them more responsive to chemotherapy.
Dr. Timothy Wang, one of the scientists in the study, said: “If you just cut nerves is it going to cure cancer? Probably not.
“At least in early phase, if you [disrupt the nerve] the tumor becomes much more responsive to chemotherapy, so we don’t see this as a single cure, but making current and future treatments more effective.”
Some trials have started in people who are having surgery to remove a stomach cancer. There has also been research suggesting nerves may have a role in prostate cancer too.
However, Dr. Timothy Wang acknowledged that there was a long way to go before this could be considered a treatment.
“With everything new in cancer, even if it looks great, when you start to roll it out to patients it always seems cancer is smarter than we are.
“Tumors have the ability to out-evolve any single agent, knocking one leg of a stool is probably not going to topple it.
“But I think this has a lot of potential and in a decade or two I can see these pathways being targeted.”
Taking aspirin every day can reduce the chance of developing or dying from bowel and stomach cancers, a Queen Mary University of London research team reports in the Annals of Oncology.
Scientists examined some 200 studies investigating the benefits and harms of taking aspirin – an area of continuing medical debate.
They found the drug reduced the number of cases and deaths from bowel, stomach and esophageal cancer by some 30-40%.
There was weaker and more variable evidence that the drug reduced deaths from breast, prostate and lung cancer too.
And the study found people needed to take the drug for at least five years to see any benefits.
Prof. Jack Cuzick, at Queen Mary University of London, who led the research, urged all healthy people aged 50 and above to consider taking a small dose (75mg) of the drug every day for a decade.
Taking aspirin every day can reduce the chance of developing or dying from bowel and stomach cancers
Researchers predicted if 1,000 individuals aged 60 took the drug for 10 years, a further decade later there would be:
16 fewer deaths from cancer
One fewer death from heart attack
Two extra deaths from bleeding
Prof. Jack Cuzick, who has been taking aspirin for four years, said: “Whilst there are some serious side-effects that can’t be ignored, taking aspirin daily looks to be the most important thing we can do to reduce cancer after stopping smoking and reducing obesity, and will probably be much easier to implement.”
They found benefits continued even when people stopped taking the drug, but say it is unclear exactly how long people should use it for.
As the risk of internal bleeding rises as an individual gets older, they suggest a cut-off point of 10 years.
There is still uncertainty whether other doses of the drug could offer more protection.
Aspirin’s well known possible side-effects include bleeding in the stomach and the brain.
Experts warn anyone at high risk of bleeding, including people with blood disorders who take blood thinning medication, or are frequent smokers or drinkers, are more likely to suffer these side-effects.
They recommend anyone considering daily medication should speak to their doctors to discuss individual risks.
Exactly how aspirin protects against cancer is unknown. Scientists suggest it may reduce inflammation or act on blood cells that would otherwise encourage the spread of the disease.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.